AGIO
Agios Pharmaceuticals, Inc.
1W: +19.3%
1M: +15.9%
3M: +24.6%
YTD: +24.5%
1Y: +11.7%
3Y: +55.6%
5Y: -29.5%
$35.20
+1.01 (+2.95%)
After Hours: $33.80 (-1.40, -3.98%)
Weekly Expected Move ±4.8%
$27
$28
$29
$31
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$13.1M
Congress1 trades
ETF Holdings—
Key Statistics
Market Cap$2.1B
52W Range22.24-46
Volume1,283,322
Avg Volume868,313
Beta0.88
Dividend—
Analyst Ratings
Company Info
CEOBrian Goff
Employees486
SectorHealthcare
IndustryBiotechnology
IPO Date2013-07-24
Websiteagios.com
88 Sidney Street
Cambridge, MA 02139-4169
US
Cambridge, MA 02139-4169
US
617 649 8600
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Latest News
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon?
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Viswanadhan Krishnan | M-Exempt | 8,100 | — | 2026-03-05 |
| Viswanadhan Krishnan | S-Sale | 2,959 | $27.80 | 2026-03-05 |
| Viswanadhan Krishnan | M-Exempt | 8,100 | — | 2026-03-05 |
| Washburn Theodore Ja | S-Sale | 5,272 | $28.88 | 2026-03-03 |
| Goff Brian | M-Exempt | 8,500 | — | 2026-03-02 |